Epstein-Barr virus (EBV) reactivation is a frequent events after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT

JWJ Esser, Ronnie van der Holt, E Meijer, HGM Niesters, R Trenschel, SFT Thijsen, AM van Loon, F Frassoni, A Bacigalupo, UW Schaefer, Ab Osterhaus, JW (S.) Gratama, Bob Löwenberg, LF Verdonck, Jan Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

323 Citations (Scopus)
26 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)972-978
Number of pages7
Issue number4
Publication statusPublished - 2001

Research programs

  • EMC MM-02-41-04
  • EMC MM-03-86-12
  • EMC MM-04-27-01

Cite this